Sonida Senior Living Debt to Equity Ratio 2010-2025 | SNDA
Current and historical debt to equity ratio values for Sonida Senior Living (SNDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sonida Senior Living debt/equity for the three months ending March 31, 2025 was 9.83.
| Sonida Senior Living Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.76B | $0.07B | 11.74 |
| 2024-12-31 | $0.76B | $0.08B | 9.74 |
| 2024-09-30 | $0.71B | $0.09B | 8.40 |
| 2024-06-30 | $0.69B | $-0.03B | -20.12 |
| 2024-03-31 | $0.68B | $-0.04B | -16.37 |
| 2023-12-31 | $0.74B | $-0.12B | -6.40 |
| 2023-09-30 | $0.73B | $-0.10B | -7.06 |
| 2023-06-30 | $0.73B | $-0.09B | -8.08 |
| 2023-03-31 | $0.73B | $-0.08B | -9.33 |
| 2022-12-31 | $0.76B | $-0.10B | -7.50 |
| 2022-09-30 | $0.76B | $-0.09B | -8.96 |
| 2022-06-30 | $0.76B | $-0.07B | -10.95 |
| 2022-03-31 | $0.77B | $-0.06B | -12.20 |
| 2021-12-31 | $0.78B | $-0.05B | -16.56 |
| 2021-09-30 | $0.83B | $-0.15B | -5.39 |
| 2021-06-30 | $0.87B | $-0.19B | -4.56 |
| 2021-03-31 | $0.93B | $-0.24B | -3.86 |
| 2020-12-31 | $0.98B | $-0.28B | -3.52 |
| 2020-09-30 | $1.00B | $-0.26B | -3.86 |
| 2020-06-30 | $1.01B | $-0.04B | -22.68 |
| 2020-03-31 | $1.01B | $-0.03B | -31.39 |
| 2019-12-31 | $1.25B | $0.01B | 87.16 |
| 2019-09-30 | $1.29B | $0.00B | 402.18 |
| 2019-06-30 | $1.31B | $0.02B | 56.63 |
| 2019-03-31 | $1.31B | $0.03B | 38.59 |
| 2018-12-31 | $1.11B | $0.04B | 31.59 |
| 2018-09-30 | $1.08B | $0.06B | 18.08 |
| 2018-06-30 | $1.09B | $0.07B | 15.79 |
| 2018-03-31 | $1.09B | $0.08B | 14.43 |
| 2017-12-31 | $1.10B | $0.08B | 13.70 |
| 2017-09-30 | $1.09B | $0.09B | 12.79 |
| 2017-06-30 | $1.10B | $0.09B | 12.04 |
| 2017-03-31 | $1.09B | $0.10B | 11.28 |
| 2016-12-31 | $1.03B | $0.12B | 8.80 |
| 2016-09-30 | $0.99B | $0.12B | 7.99 |
| 2016-06-30 | $0.94B | $0.13B | 7.38 |
| 2016-03-31 | $0.92B | $0.13B | 7.11 |
| 2015-12-31 | $0.88B | $0.14B | 6.51 |
| 2015-09-30 | $0.82B | $0.14B | 5.87 |
| 2015-06-30 | $0.79B | $0.14B | 5.86 |
| 2015-03-31 | $0.77B | $0.14B | 5.64 |
| 2014-12-31 | $0.75B | $0.14B | 5.31 |
| 2014-09-30 | $0.74B | $0.14B | 5.13 |
| 2014-06-30 | $0.69B | $0.15B | 4.70 |
| 2014-03-31 | $0.59B | $0.16B | 3.81 |
| 2013-12-31 | $0.59B | $0.16B | 3.72 |
| 2013-09-30 | $0.50B | $0.16B | 3.17 |
| 2013-06-30 | $0.49B | $0.17B | 2.89 |
| 2013-03-31 | $0.46B | $0.17B | 2.75 |
| 2012-12-31 | $0.47B | $0.17B | 2.78 |
| 2012-09-30 | $0.39B | $0.17B | 2.31 |
| 2012-06-30 | $0.39B | $0.17B | 2.29 |
| 2012-03-31 | $0.34B | $0.17B | 1.98 |
| 2011-12-31 | $0.29B | $0.17B | 1.73 |
| 2011-09-30 | $0.27B | $0.17B | 1.60 |
| 2011-06-30 | $0.23B | $0.17B | 1.39 |
| 2011-03-31 | $0.21B | $0.17B | 1.29 |
| 2010-12-31 | $0.22B | $0.16B | 1.34 |
| 2010-09-30 | $0.22B | $0.16B | 1.38 |
| 2010-06-30 | $0.22B | $0.16B | 1.37 |
| 2010-03-31 | $0.22B | $0.16B | 1.37 |
| 2009-12-31 | $0.22B | $0.16B | 1.41 |
| 2009-09-30 | $0.23B | $0.16B | 1.43 |
| 2009-06-30 | $0.23B | $0.16B | 1.46 |
| 2009-03-31 | $0.23B | $0.16B | 1.46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.481B | $0.304B |
| Sonida Senior Living is an owner-operator of senior living communities and services. Sonida Senior Living, formerly known as Capital Senior Living Corporation, is based in DALLAS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.424B | 27.27 |
| CVS Health (CVS) | United States | $85.300B | 10.60 |
| Elevance Health (ELV) | United States | $78.589B | 10.14 |
| Cencora (COR) | United States | $57.416B | 19.98 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.088B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.920B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.673B | 0.00 |
| Solventum (SOLV) | United States | $13.582B | 14.38 |
| CochLear (CHEOY) | Australia | $12.960B | 0.00 |
| ICON (ICLR) | Ireland | $12.122B | 11.27 |
| Revvity (RVTY) | United States | $11.941B | 20.55 |
| Viatris (VTRS) | United States | $10.939B | 3.76 |
| Avantor (AVTR) | United States | $9.458B | 13.74 |
| Medpace Holdings (MEDP) | United States | $9.240B | 24.54 |
| HealthEquity (HQY) | United States | $8.834B | 38.70 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.717B | 15.12 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.752B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.910B | 28.92 |
| BrightSpring Health Services (BTSG) | United States | $3.889B | 35.68 |
| Sotera Health (SHC) | United States | $3.334B | 18.94 |
| Surgery Partners (SGRY) | United States | $2.839B | 36.92 |
| Alignment Healthcare (ALHC) | United States | $2.685B | 0.00 |
| Concentras Parent (CON) | United States | $2.635B | 15.23 |
| GeneDx Holdings (WGS) | United States | $2.614B | 100.67 |
| Organon (OGN) | United States | $2.589B | 2.75 |
| PACS (PACS) | United States | $2.003B | 0.00 |
| Ardent Health (ARDT) | United States | $1.915B | 8.16 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.812B | 13.76 |
| GoodRx Holdings (GDRX) | United States | $1.682B | 33.64 |
| Teladoc Health (TDOC) | United States | $1.454B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.259B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.184B | 9.01 |
| CareDx (CDNA) | United States | $1.071B | 16.73 |
| Agilon Health (AGL) | United States | $1.006B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.86 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| Embecta (EMBC) | United States | $0.603B | 4.06 |
| InnovAge Holding (INNV) | United States | $0.602B | 0.00 |
| LifeMD (LFMD) | United States | $0.568B | 0.00 |
| Omada Health (OMDA) | $0.480B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| SBC Medicals (SBC) | United States | $0.463B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 31.88 |
| So-Young (SY) | China | $0.330B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.328B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.305B | 0.00 |
| Beauty Health (SKIN) | United States | $0.287B | 0.00 |
| Oncology Institute (TOI) | United States | $0.225B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 26.33 |
| Pheton Holdings (PTHL) | China | $0.126B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.094B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |